Back
Karuna Therapeutics Stock Price Chart
The U.S. Government Just Invested $140 Million In WHAT?
And he shows you exactly how to take advantage right here, starting today.
Buy
70
KRTX
Karuna Therapeutics
Last Price:
227.57
Seasonality Move:
41.04%
7 Day Trial
ALL ACCESS PASS
$
7
FedCoin Is REAL (And Coming Soon)
Every American should be making this one crucial move, ASAP.- The current trend is moderately bullish and KRTX is experiencing selling pressure, which indicates risk of future bearish movement.
Karuna Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 231.71 | Sell |
| 20-day SMA: | 226.58 | Buy |
| 50-day SMA: | 208.52 | Buy |
| 200-day SMA: | 209.97 | Buy |
| 8-day EMA: | 230.37 | Sell |
| 20-day EMA: | 225.44 | Buy |
| 50-day EMA: | 214.05 | Buy |
| 200-day EMA: | 196.82 | Buy |
Karuna Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 6.24 | Buy |
| Relative Strength Index (14 RSI): | 56 | Buy |
| Chaikin Money Flow: | -269397 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (219.77 - 231.05) | Buy |
| Bollinger Bands (100): | (182.59 - 216.53) | Buy |
Karuna Therapeutics Technical Analysis
| May-26 | May-30 | May-31 | Jun-1 | Jun-2 | Jun-5 | Jun-6 | Jun-7 | Jun-8 | Jun-9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | Jun | |||||||||
| 26 | 30 | 31 | 01 | 02 | 05 | 06 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Karuna Therapeutics Stock
Is Karuna Therapeutics Stock a Buy?
- Karuna Therapeutics share price is 227.62 while KRTX 8-day simple moving average is 231.71, which is a Sell signal.
- The stock price of KRTX is 227.62 while Karuna Therapeutics 20-day SMA is 226.58, which makes it a Buy.
- Karuna Therapeutics 50-day simple moving average is 208.52 while KRTX share price is 227.62, making it a Buy technically.
- KRTX stock price is 227.62 and Karuna Therapeutics 200-day simple moving average is 209.97, creating a Buy signal.
KRTX Technical Analysis vs Fundamental Analysis
Buy
70
Karuna Therapeutics (KRTX)
is a Buy
Is Karuna Therapeutics a Buy or a Sell?
-
Karuna Therapeutics stock is rated a Buy
The current Karuna Therapeutics [KRTX] share price is $227.62. The Score for KRTX is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
Karuna Therapeutics Stock Info
Market Cap:
8.52B
Price in USD:
227.62
Share Volume:
284.84K
Karuna Therapeutics 52-Week Range
52-Week High:
278.25
52-Week Low:
93.47
Buy
70
Karuna Therapeutics (KRTX)
is a Buy
Karuna Therapeutics Share Price Forecast
-
What is the Karuna Therapeutics stock price today?
The Karuna Therapeutics stock price is 227.62 USD today. -
Will KRTX stock go up or go down?
Karuna Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Karuna Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Karuna Therapeutics is not overvalued.
Is Karuna Therapeutics Stock a Buy?
- Karuna Therapeutics share price is 227.62 while KRTX 8-day exponential moving average is 230.37, which is a Sell signal.
- The stock price of KRTX is 227.62 while Karuna Therapeutics 20-day EMA is 225.44, which makes it a Buy.
- Karuna Therapeutics 50-day exponential moving average is 214.05 while KRTX share price is 227.62, making it a Buy technically.
- KRTX stock price is 227.62 and Karuna Therapeutics 200-day simple moving average is 196.82, creating a Buy signal.
Fundamental Analysis of Karuna Therapeutics
Is Karuna Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.70 per share, a decrease next quarter of $0.45 per share, a decrease this year of $2.74 per share, and an increase next year of $0.65 per share.
Technical Analysis of Karuna Therapeutics
Should I short Karuna Therapeutics stock?
- KRTX Moving Average Covergence Divergence (MACD) indicator is 6.24, suggesting Karuna Therapeutics is a Buy
- Karuna Therapeutics Relative Strength Index (RSI) is 56, which suggest Karuna Therapeutics is overbought
- The Bollinger Bands (25) for Karuna Therapeutics is (219.77 - 231.05), which suggest Karuna Therapeutics is a Buy
- The Bollinger Bands (100) for Karuna Therapeutics is (182.59 - 216.53), which suggest Karuna Therapeutics is a Buy
* Karuna Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.